Bass Boats Market 2020 Covid-19 Impact by Supply, Demand, Components, Trends, Size, Share and more…

A new market study, titled “2020 Global Bass Boats Market Outlook”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, May 29, 2020 /EINPresswire.com/ — Bass Boats Market

This report focuses on Bass Boats volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bass Boats market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Ranger Boats
SeaArk Boats
Sea Chaser
Skeeter
Stratos
Tracker
Triton Boats
Nitro
Polar Kraft
Crestliner
Lund Boats
Beavertail Skiffs
Bass Cat Boats
Alumacraft

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4742690-2020-global-bass-boats-market-outlook

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Side Console
Dual Console
Others

Segment by Application
Bottom Fishing
Sports Fishing
Others

View Detailed Report at https://www.wiseguyreports.com/reports/4742690-2020-global-bass-boats-market-outlook

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+ +1 646-845-9349
email us here


Source: EIN Presswire

Dr. Eugene Gu: Changing the World Through Cool Quit

Dr. Eugene Gu

Dr. Eugene Gu

LOS ANGELES, CA, USA, May 28, 2020 /EINPresswire.com/ — When it comes to changing the world in the midst of the coronavirus pandemic, not many have been as effective as Dr. Eugene Gu. Dr. Gu is the CEO and co-founder of Cool Quit, LLC, a smoking cessation telemedicine company that has now turned its attention, infrastructure, and resources to the fight against COVID-19. "It may sound like a platitude by now, but I truly do believe that we are all in this together. That means we must all do what we can whether we are big or small to help each other and the American people during the worst pandemic in modern history."

With new updates to Cool Quit, it seems that Dr. Eugene Gu's stock is on the rise. "We are very happy to announce that we can now offer at-home coronavirus testing kits to patients." Eugene Gu said when talking about the latest telemedicine innovation in his product line. "We have effectively been able to leverage the changing healthcare laws and expansion of telemedicine allowances to get people free telehealthcare and even free home testing kits that are reimbursed by their insurance companies."

Before the at-home coronavirus testing kits were announced, however, Cool Quit had been already putting in the work with free COVID-19 screening, evaluation, and testing for elderly Medicare patients in 42 states including Alabama, Arizona, California, Florida, Georgia, Indiana, Iowa, Maine, Michigan, Montana, New Hampshire, New Jersey, New York, New Mexico, North Carolina, Ohio, Oklahoma, Pennsylvania, Tennessee, Texas, Utah, Vermont, Washington, and West Virginia. "It was a huge deal and I am happy to say that thanks to the flexibility of our staff as well as our ability to stay vigilant and nimble, we were able to get testing set up in those locations and even rural underserved areas that needed it the most." Eugene Gu noted. "I think that right now, it is important for us to stand up for those that need help the most, and that means our elderly seniors who are most affected by this pandemic. We also are reaching out to patients with underlying health conditions like obesity, diabetes, hypertension." Eugene Gu continued.

Eugene Gu, it should be noted, is a Stanford trained medical doctor who found his way into the medical testing world. "It was a way for me to do something greater than just seeing patients one on one. I found it to be a way to impact communities in a more positive way." Eugene Gu said. "I found that developing telemedicine tools and health monitoring programs could impact more people at once than my practice ever could."

Eugene Gu is also quick to point out how impressed he is with the doctors within his own organization and their ability to react in times of crisis. "I think it is important that physicians always put their patients first." Eugene Gu noted. "For many of our physicians at Cool Quit, telemedicine is a completely new technology to them." Eugene Gu continues. "But they learned quickly and adapted to the rapidly changing healthcare needs that the worst pandemic in modern history requires. I couldn’t be more proud of their hard work and dedication".

About Eugene Gu
Dreugenegu.com
LinkedIn
YouTube

Caroline Hunter
Web Presence, LLC
+1 786-233-8220
email us here
Visit us on social media:
Twitter
LinkedIn

Eugene Gu


Source: EIN Presswire

Voip-Pal CEO Emil Malak explains that we are in a Global War with the Coronavirus

VOIP-PAL Corporate Logo

VOIP-PAL CEO Emil Malak

CEOCFO Magazine logo

In an interview with CEOCFO Magazine, VOIP-PAL CEO and Director Emil Malak discusses the asymptomatic COVID-19, the reopening of states and the airlines

Voip-Pal (OTCQB:VPLM)

Requiring each passenger to show a current negative test result before boarding will restore confidence in the safety of air travel.”

— Emil Malak

WASHINGTON, DC, US, May 28, 2020 /EINPresswire.com/ — CEOCFO Magazine, an independent investment publication that highlights important technologies and companies, today announced an interview and op-ed (https://www.ceocfointerviews.com/voippaloped7052620.html) with Emil Malak, CEO of Voip-Pal (OTCQB: VPLM), a Bellevue, Washington based company, inventers and pioneers of the switching technology now being used by many of the world's largest telecommunication and social networking companies, without which they could not connect Landline phone calls to Internet phone calls.

Mr. Malak has many other business ventures and is well versed on the coronavirus pandemic and its possible spread. Mr. Malak explained that, “We must treat COVID-19 like other killer diseases, such as cancer, heart problems, diabetes, pulmonary issues, and lupus etc.” However, Mr. Malak points to out that the major difference in this disease is that it has managed to hide, as it is asymptomatic and now it is crippling our economies. He says, “Asymptomatic: patients do not show any clinical symptoms, have normal chest imaging, but yield a positive nucleic acid test. They become silent, invisible, and lethal vectors of COVID-19, being just as likely to spread the virus as a symptomatic patient. Children are more likely to be asymptomatic carriers of COVID-19 than adults. It is believed that between 10% to 15% or more of carriers are asymptomatic. It only takes one to infect dozens, hundreds or even thousands of people in an enclosed environment.”

Since we seem to be in a global war, and every country would need a marshal plan in order to get back their economies. When asked what a marshal plan to combat the coronavirus should look like, Mr. Malak responded, “The Coronavirus Marshal Plan begins with executing the right testing strategy. Mobile testing vans need to be deployed and visible in every community. Once a person is tested, their current test results would be displayed on their smartphone. As long a person tests negative, they could move about freely. Anyone who tests positive can receive early treatment and isolate themselves to avoid spreading the virus to their family and friends, and avoid mass spreading within the community.

Only testing everyone continuously is the solution according to Mr. Malak, “Tests should be repeated on a weekly basis to ensure each person has an accurate current result. This provides the only safe way forward. By implementing this coronavirus Marshal Plan we will be able to fully reopen the economy without worrying about a surge of new infections or increased mortality rates. Businesses will be positioned to soar once again to their pre-COVID-19 heights. Testing frequencies can always be reviewed and adjusted as needed.”

As to what we would need to do to get international air travel back to normal, Mr. Malak responds, “In my proposal, airlines would provide testing to each passenger no longer than 48 hours before boarding the plane. In some instances, they can even offer the test at the airport. Only passengers with a negative test result would be permitted to board the plane. A passenger would take the test prior to their outbound flight and again before their return flight. Requiring each passenger to show a current negative test result before boarding will restore confidence in the safety of air travel.”

Is China the new evil empire requiring everyone to cut trade with them? Mr. Malak told CEOCFO's Bud Wayne, “The people who make up the silent majority in the United States and Europe realize that China has not been truthful. They can see through the lies and how China has benefited economically from the coronavirus pandemic while the rest of the world suffers greatly – the Chinese regime is laughing all the way to the bank! It is time for the world’s leaders to come together and stop all dealings with the Chinese government. China must suffer consequences for the pain and suffering they have unleashed on the world. Additionally, severing ties with the Chinese will create millions and millions of jobs outside of China and help countries once again become self-sufficient. This is no time for globalization or bowing to the interests of the World Trade Organization (WTO) that has shown so much bias in favor of the Chinese and has helped spread the Chinatization of much of the world.”

Bud Wayne
CEOCFO Magazine
+1 570-851-1745
email us here


Source: EIN Presswire

Research at MDI Biological Laboratory Explores Novel Pathways of Regeneration and Tumorigenesis

Dustin Updike, Ph.D., of the MDI Biological Laboratory in Bar Harbor, Maine

Dustin Updike's research on germ granules offers another route to repairing damaged tissues and organs in cases where therapeutic options are limited or non-existent.”

— Hermann Haller, M.D, president, MDI Biological Laboratory

BAR HARBOR, MAINE, UNITED STATES, May 28, 2020 /EINPresswire.com/ — Research by scientists at the MDI Biological Laboratory in Bar Harbor, Maine, is opening up new approaches to promoting tissue regeneration in organs damaged by disease or injury.

In recent years, research in regenerative biology has focused on stem cell therapies that reprogram the body’s own cells to replace damaged tissue, which is a complicated process because it involves turning genes in the cell’s nucleus on and off.

A recent paper in the journal Genetics by MDI Biological Laboratory scientist Elisabeth Marnik, Ph.D., a postdoctoral fellow in the laboratory of Dustin Updike, Ph.D., offers insight into an alternate pathway to regeneration: by recreating the properties of germ cells.

Germ cells, which are the precursors to the sperm and egg, are considered immortal because they are the only cells in the body with the potential to create an entirely new organism. The stem cell-like ability of germ cells to turn into any type of cell is called “totipotency.”

“By getting a handle on what makes germ cells totipotent, we can promote regeneration by unlocking the stem cell-like properties of other cell types,” said Updike. “Our research shows that such cells can be reprogrammed by manipulating their cytoplasmic composition and chemistry, which would seem to be safer and easier than changing the DNA within a cell’s nucleus.”

Using the tiny, soil-dwelling nematode worm, C. elegans, as a model, the Updike lab studies organelles called germ granules that reside in the cytoplasm (the contents of the cell outside of the nucleus) of germ cells. These organelles, which are conserved from nematodes to humans, are one of the keys to the remarkable attributes of germ cells, including the ability to differentiate into other types of cells.

In their recent paper entitled “Germline Maintenance Through the Multifaceted Activities of GLH/Vasa in Caenorhabditis elegans P Granules,” Updike and his team describe the “intriguing and elusive” role of “Vasa” proteins within germ granules in determining whether a cell is destined to become a germ cell with totipotent capabilities or a specific type of cell, like those that comprise muscle, nerves or skin.

Because of the role of Vasa proteins in preserving totipotency, an increased understanding of how such proteins work could lead to unprecedented approaches to de-differentiating cell types to promote regeneration; or alternatively, to new methods to turn off totipotency when it is no longer desirable, as in the case of cancer.

“The increase in chronic and degenerative diseases caused by the aging of the population is driving demand for new therapies,” said MDI Biological Laboratory President Hermann Haller, M.D. “Dustin’s research on germ granules offers another route to repairing damaged tissues and organs in cases where therapeutic options are limited or non-existent, as well as an increased understanding of cancer.”

Because of the complexity of the cellular chemistry, research on Vasa and other proteins found in germ granules is often overlooked, but that is rapidly changing — especially among pharmaceutical companies — as more scientists realize the “impact and potential” of such research, not only for regenerative medicine but also for an understanding of tumorigenesis, or cancer development, Updike said.

Recent research has found that some cancers are accompanied by the mis-expression of germ granule proteins, which are normally found only in germ cells. The mis-expression of these germ-granule proteins seems to promote the immortal properties of germ cells, and consequently tumorigenesis, with some germ-granule proteins now serving as prognosis markers for different types of cancer, Updike said.

Updike is a former postdoctoral researcher in the laboratory of Susan Strome, Ph.D., at University of California, Santa Cruz. Strome, who was inducted into the National Academy of Sciences last year, first discovered P granules more than 30 years ago. She credits Updike, who has published several seminal papers on the subject, with “great imagination, determination and excellent technical skill” in the pursuit of his goal of elucidating the function and biochemistry of these tiny organelles.

The lead author of the new study from the Updike laboratory, Elisabeth A. Marnik, Ph.D., will be launching her own laboratory at Husson University in Bangor, Maine, this fall. Other contributors include J. Heath Fuqua, Catherine S. Sharp, Jesse D. Rochester, Emily L. Xu and Sarah E. Holbrook. Their research was conducted at the Kathryn W. Davis Center for Regenerative Biology and Medicine at the MDI Biological Laboratory.

Updike’s research is supported by a grant (R01 GM-113933) from the National Institute of General Medical Sciences (NIGMS), an institute of the National Institutes of Health (NIH). The equipment and cores used for part of the study were supported by NIGMS-NIH Centers of Biomedical Research Excellence and IDeA Networks of Biomedical Research Excellence grants P20 GM-104318 and P20 GM-203423, respectively.

About the MDI Biological Laboratory

We aim to improve human health and healthspan by uncovering basic mechanisms of tissue repair, aging and regeneration, translating our discoveries for the benefit of society and developing the next generation of scientific leaders. For more information, please visit mdibl.org.

Stefanie Matteson
MDI Biological Laboratory
+1 201-787-7427
email us here


Source: EIN Presswire

AACR Integrates with Code Ocean

This is an example of a Code Ocean compute capsule associated to a article published in Cancer Research in

Code Ocean compute capsule associated to an article published in Cancer Research

American Association for Cancer Research Journals Integrate Code Ocean to Help Improve Research Reproducibility

NEW YORK, NY, UNITED STATES, May 28, 2020 /EINPresswire.com/ — Code Ocean, a computational reproducibility platform, is pleased to announce that the American Association for Cancer Research (AACR), the largest professional organization related to cancer research, will integrate Code Ocean into the AACR journals platform.

Code Ocean enables authors to share fully functional and executable code accompanying their articles and to allow readers to re-run the analysis in the cloud and reproduce the results, bypassing the need to install the software. Authors upload their software code, with either test or actual raw data, to the Code Ocean online software environment. Code Ocean then verifies the code and, once the article is published, allows others to easily run, edit, and reuse the code from any web browser.

“The integration of Code Ocean into the journal platform will increase the impact of the AACR journals by allowing researchers to deposit their code and data essential to reproducing research results,” said Christine Battle, Publisher and Vice President, Scientific Publications at the AACR. “The mission of all AACR journals is to publish robust, hypothesis-driven science in order to further our knowledge of cancer while promoting rigor and reproducibility.”

“It is an honor to be working with the AACR, a leader in cancer research. The integration of Code Ocean into the AACR journals platform furthers our mission to make computational research easier, more collaborative, and durable. Computational biology and bioinformatics are fast becoming a critical area of importance and are a focus for Code Ocean as funders’ requirements demand more transparency.” said Simon Adar, CEO and Co-founder of Code Ocean.

The AACR will deploy Code Ocean across all nine of the AACR journals on May 21, 2020. Within the manuscript submission process via the AACR’s implementation of the EJPress online submission and peer review system authors will be invited to submit their code, creating an efficient way to associate these first-class research objects with their manuscript. Upon publication of the code, Code Ocean generates a citable Digital Object Identifier (DOI) to increase author attribution of code as part of their publication record; reviewers and other readers of the submitted manuscript will be able reproduce for themselves, using the Code Ocean online software environment, the computational analyses reported by the authors in their manuscript.

The full press release can be found here

ABOUT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)

The AACR is the largest professional organization dedicated to advancing cancer research and its mission to prevent and cure all cancers. The organization was founded in 1907, and its membership includes more than 47,000 laboratory, translational, and clinical researchers; population scientists; other healthcare professionals; and patient advocates residing in 127 countries.

ABOUT CODE OCEAN

Code Ocean is a cloud-based computational reproducibility platform that provides researchers in academia and biopharma with an easy way to develop, share, and run code. Code Ocean streamlines computational research with an integrated management platform so researchers can start projects (called compute capsules) faster, can collaborate easily and don't have to worry about computing resources. Once published, compute capsules are preserved for reproducibility, data provenance and reuse.

Pierre Montagano
Code Ocean
+1 215-460-8344
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Techcyte Expands its Board and Adds World-Class Advisers to its Team

Techcyte recently expanded its board and advisory team through the addition of world-class medical, corporate strategy, and laboratory diagnostics experts.

To pursue our go-to-market strategy, we can’t do it alone. Our advisers have been invaluable in focusing our efforts on the highest value markets and tests.”

— Ben Cahoon, Techcyte CEO

LINDON, UT, UNITED STATES, May 28, 2020 /EINPresswire.com/ — Techcyte recently expanded its board and advisory team through the addition of world-class medical, corporate strategy, and laboratory diagnostics experts. Techcyte is currently developing and selling its deep learning image analysis platform to human, veterinary, and air quality laboratories throughout the world.

Ben Cahoon, the new CEO of Techcyte, said, “To pursue our go-to-market strategy, we can’t do it alone. Our advisers have been invaluable in focusing our efforts on the highest value markets and tests.”

Techcyte Board
– Dr. Mohamed Salama, Hematopathologist & Chief Medical Officer, Mayo Clinic Laboratories
– Kent Gordon, Chief Financial Officer, ARUP Reference Laboratories
– Michael Aicher – President, Alveo Technologies
– Kyle Wilson – Partner, BroadOak Capital Partners
– Ralph Yarro – Founder, Chairman of the Board, Techcyte
– Michael Wolfgramm – Partner, Atua Ventures
– Ben Cahoon – CEO, Techcyte
– Rick Smith – President, Techcyte

Advisers
– Dr. David Gardiner – Veterinary Pathologist
– Dr. John Haines – Retired Mycologist for New York State
– Dr. Angelica Rodriguez Baca – Cytopathologist
– Dr. Stéphane Gidenne – CEO, Ketterthill Laboratory, Luxembourg
– Richard Johnson – CEO of Air Allergen and Mold Testing

As Techcyte expands its platform to provide additional solutions, we’ll continue to look for additional world-class experts to guide and direct our efforts. If you’re interested in using or integrating with the Techcyte deep learning image analysis platform to create new algorithms or markets, please contact Ben Cahoon. ben.cahoon@techcyte.com.

###
About Techcyte
Headquartered in Lindon, Utah, Techcyte, Inc. was founded in 2013 and is the world leader in AI-based cellular digital diagnostics. Techcyte's use of deep machine learning to perform automated analysis of whole slide microscopy images is revolutionizing digital diagnostics in research, biopharma, environmental monitoring, and human and animal health. Visit www.techcyte.com for more information.

Techcyte Media Contact:
Matt Yarro, 801-980-0414, matt.yarro@techcyte.com

Matt Yarro
Techcyte, Inc.
+1 801-980-0414
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

SASKATCHEWAN WELCOMES NRGene TO PROVINCE – Leading Genomics Company Expands Operations to Canada with Saskatoon Office

NRGene logo

NRGene has been involved in Saskatchewan’s wheat genome project

NRGene, a genomics AI company that provides turn-key solutions to support agricultural research and breeding will be opening an office in Saskatoon, Canada.

With the world class agricultural research cluster in Saskatoon, the burgeoning AgTech sector, and a strong history of primary production, we see in Canada a natural location to expand our operations”

— Dr. Gil Ronen, CEO and Co-founder, NRGene

NESS ZIONA, ISRAEL, May 28, 2020 /EINPresswire.com/ — The Government of Saskatchewan is welcoming NRGene, a leading genomics company, to the province. Headquartered in Israel, the company announced they are expanding their operations to Canada and will be opening an office in Saskatoon.

This investment from NRGene follows a successful trade mission to Israel in 2018, where the Honorable Jeremy Harrison, Minister of Trade and Export Development, and Deputy Premier Gordon Wyant met with the company to highlight opportunities in Saskatchewan. The purpose of the trade mission was to showcase Saskatchewan’s business environment and our world class agriculture sector, as well as to encourage Israeli companies to establish a presence in the province.

“This announcement is good news for Saskatchewan and it is a positive sign that the province’s investment climate remains strong, despite the current challenges due to the global COVID-19 pandemic,” Harrison said. “NRGene will be a great fit for Saskatchewan’s agricultural sciences cluster, bringing good jobs and capacity that will enhance our innovative AgTech, and increasing productivity in the agri-food sector.”

NRGene is a genomics AI company that provides turn-key solutions to support agricultural research and breeding. Relying on a vast proprietary genomic databases and AI-based technologies, NRGene provides some of the largest ag-based companies in the world with the computational tools they require to improve breeding of crop plants and farm animals, thus increasing food production from every acre of agricultural land. NRGene’s tools have been implemented by leading seed, ag-chemical and ag biotech companies worldwide, as well as by many influential research teams in academia.

The Government of Saskatchewan has been working with NRGene since 2015, when Innovation Saskatchewan first met with NRGene’s team at a workshop, as they have been involved in Saskatchewan’s wheat genome project demonstrating how advanced genomics technology can boost wheat yield. Since then, NRGene has generated multiple successful collaborations in Saskatchewan with the University of Saskatchewan, the Global Institute for Food Security (GIFS), Agriculture & Agri-Food Canada (AAFC) and additional local commercial companies and academia. These collaborations cover multiple crops, including bread-wheat, durum wheat, canola, legumes, mustard, flax, cannabis and more.

In January 2020, it was announced that an international consortium, including GIFS researchers at the University of Saskatchewan and NRGene, had successfully completed the assembly of multiple canola reference genomes.

“With the world class agricultural research cluster in Saskatoon, the burgeoning AgTech sector, and such a strong history of primary production, we see in Canada a natural location for NRGene to expand its operations,” says CEO and co-founder of NRGene, Doctor Gil Ronen. “We know this firsthand, having recently collaborated on the exciting genomics projects in wheat and canola, so we are pleased to make this important investment in Saskatchewan.” With this investment in the province, NRGene will recruit skilled geneticists and data scientists to their new office in Saskatoon.

Continued international engagement and dialogue with companies like NRGene will continue to be a priority as the province works towards economic recovery.

For more information, please contact:

Ashley Schoff
Trade and Export Development
306-787-5582
Ashley.schoff2@gov.sk.ca

Yana Voldman
NRGene
+972 50-900-2844
email us here
Visit us on social media:
Twitter
LinkedIn


Source: EIN Presswire

Bone Index Will Launch World’s First Science-based Fracture Prevention Program in U.S.

The world’s first science-based, personalized fracture prevention program which key objective is to prevent the most significant risk factor of osteoporotic bone fracture – the first fracture.

Bindex Total Bone Health™ – prevent the first fracture

Bindex Total Bone Health – Personalized fracture prevention regimen

In addition, all Medicare Advantage plans should provide this prevention program to help their members reduce fractures and maintain independence and quality of life.”

— Dr. Kerri O’Brien

DALLAS, TEXAS, USA, May 28, 2020 /EINPresswire.com/ — Bone Index Ltd., a healthcare diagnostics company with the game-changing hand-held osteoporosis diagnostics technology (Bindex®), today announced that they will launch the world’s first science-based, personalized fracture prevention program, Bindex Total Bone Health™ in the U.S. The key objective of the program is to prevent the most significant risk factor of osteoporotic bone fracture – the first fracture. A prior fracture is associated with an 86% increased risk of any fracture (1).

Bone mineral density will naturally decrease with age. The entire Medicare population is a high-risk group for osteoporosis and falls. Unfortunately, osteoporosis is rarely diagnosed and there are no systematic fracture prevention actions used. Therefore, the annual cost of fractures is over $20 billion in the U.S. (2). Shockingly, osteoporosis-related bone fractures are responsible for more hospitalizations than heart attacks, strokes and breast cancer combined (2).

“Bindex Total Bone Health™ is based on reliable and accurate Bindex® osteoporosis screening (3) which provides a personalized, science-based program to build strong bones and improve stability through integrated strength and balance training, along with tailored nutritional improvements, helping to reduce falls and fractures.” says Bone Index's CEO, Dr. Ossi Riekkinen.

“This program is essential for all gyms and fitness programs which provide services for the 50+ population, specifically those on Medicare. In addition, all Medicare Advantage plans should provide this prevention program to help their members reduce fractures and maintain independence and quality of life.” says Bone Index's Business Development Consultant, Dr. Kerri O’Brien.

There are several pharmaceutical treatment options available for osteoporosis to help prevent fractures, but these options are only available after osteoporosis diagnosis and/or fracture. Naturally, bone mineral density will decrease significantly with age, but with the correct active lifestyle the patient may achieve even twenty more fracture-free years compared to a sedentary lifestyle (4). However, to prevent fractures and injuries at the needed level, a personalized, science-based program to build strong bones and great balance as a combination is the most effective.
“At the moment, unique Bindex bone scan technology is widely used in the U.S. and over 1.6 million patients have been measured. We are currently selecting the best co-operation partners to provide and adjust Bindex Total Bone Health™ to best meet the needs of their members and patients. The partners should have an interest in improving the health and well-being of their members and lowering overall healthcare costs.” says Dr. Riekkinen.

For more information:
www.totalbonehealth.com

Dr. Kerri O’Brien, Business Development Consultant, Tampa, Florida
kobrien@bottomlineweightloss.com , Tel: 602.316.3267

Ms. Robin Raff, Board member, Bone Index Ltd., Walnut Creek, California
robin@pulsehealthcaremarketing.com , Tel: 925.788.3173

Dr. Ossi Riekkinen, CEO, Bone Index Ltd., Dallas, TX
ossi.riekkinen@boneindex.fi , Tel: 469.805.5419, www.bindex.us

References:
1) Kanis JA et al. (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375.
2) National Osteoporosis Foundation
3) The Bindex® point-of-care device measures the cortical bone thickness of the tibia and the algorithm calculates the Density Index, a parameter that estimates bone mineral density at the hip as measured with DXA. Bindex® detects osteoporosis with 90% sensitivity and specificity.
American Medical Association has issued a new reimbursement code for Bindex® and the Centers for Medicare & Medicaid Services (CMS) has approved coverage for the code in several settings.
CPT Code, 0508T: Pulse-echo ultrasound bone density measurement resulting in indicator of axial bone mineral density, tibia.
4) International Osteoporosis Foundation

About Bone Index:
Founded in 2011 in Kuopio, Bone Index Finland Ltd. has developed the game-changer point-of-care technology (Bindex®) in osteoporosis screening/diagnostics. With Bindex Total Bone Health™ the company is entering the fall and fracture prevention program segment in U.S.

Dr. Ossi Riekkinen, CEO
Bone Index Ltd. (Bindex)
+1 469-805-5419
email us here
Visit us on social media:
LinkedIn

Bindex® is the game-changing hand-held osteoporosis diagnostics technology


Source: EIN Presswire

Embolic Protection Devices Market Size to Reach Revenues of over $688 Million by 2025 – Arizton

Embolic protection devices market size is expected to reach $688 million by 2025, growing at a CAGR of 8% during 2020-2025

CHICAGO, ILLINOIS, UNITED STATES, May 28, 2020 /EINPresswire.com/ — The embolic protection devices market share is expected to grow at a CAGR of over 8% during the period 2020–2025.

According to Arizton, several factors will continue to influence the growth of global embolic protection devices market. For instance, growing demand for cerebral embolic protection devices by preventing various procedural debris to travel to the brain during neurovascular procedures to reduce the risk of stoke is expected to drive the market growth of the global embolic protection devices market. In addition, significant shift from open to minimally invasive surgery technique for various cardiovascular and neurovascular diseases and potential long tern cost effectiveness offered by EPDs is likely to fuel the market growth of the global embolic protection devices market.

Arizton’s recent market research report considers the present scenario of the embolic protection devices market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Get your free sample now!

Embolic Protection Devices Market – Dynamics

Here are the list of trends and drivers that are impacting the revenues and profitability in the embolic protection devices market:
• Rising Patient Pool
• Growing Demand for Cerebral Embolic Protection Device
• Rising Demand for Minimally Invasive Vascular Surgeries
• Emergence of Advanced EPDs
• Promising Investigational Devices
• New Product Approval

Embolic Protection Devices Market – Segmentation

This research report includes a detailed segmentation by product, application, indication, end-user, and geography.
• The filter devices segment accounts for the maximum market share. This is due to effective clinical results for percutaneous and transcatheter surgical techniques to treat cardiac and neuro disorders. It is expected to grow at the highest CAGR owing to greater safety and procedural outcomes.
• The cardiac & peripheral segment is expected to retain its market dominance during the forecast period. Filter or occlusion embolic protection devices have proven clinical benefits and can be used when technically feasible for cardiac & peripheral applications. As a result, there is a huge demand for EPDs for treating CVDs across the globe.
• EPDs have become a standard for anatomically suitable patients undergoing SVG PCI. Therefore, many players have been focusing on the development of clinically advanced EPD for SVG disease over the years. This is increasing the global embolic protection devices market size.

Segmentation by Product
• Filters
• Occlusions
Segmentation by Application
• Cardiovascular & Peripheral
• Neurovascular
Segmentation by Indication
• SVG
• Carotid Artery Diseases
• Others
o Aortic Stenosis
o Peripheral Artery Disease
o Acute Myocardial Infraction
Segmentation by End-user
• Hospitals
• Specialty Cardiac Centers
• ASCs
• Freestanding CATH Labs

Embolic Protection Devices Market – Geography

North America is the single largest market for embolic protection companies. The region has become strategically important for several prominent vendors, such as Boston Scientific and Abbott. Medtronic embolic protection devices are expected to be innovative as the company is investing significant expenditure in R&D. The US is the major revenue contributor to the market, accounted for a share of 90% in 2019.

Get your free sample now! https://www.arizton.com/market-reports/embolic-protection-devices-market

Segmentation by Geography
• North America
o US
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
• APAC
o China
o Japan
o India
o South Korea
o Australia
• Latin America
o Brazil
o Argentina
o Mexico
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE

Embolic Protection Devices Market – Vendor Landscape

The global embolic protection devices market share is highly concentrated. The market has the presence of few established players holding the majority of the market share. Vendors are offering several filter and occlusion embolic protection devices. They are competing based on factors such as technology advances, safety features, regulatory approvals, marketing strategies, and distribution channels.

Prominent Vendors
• Boston Scientific
• Abbott
• Medtronic

Other Prominent Vendors
• Cardinal Health
• Cardiovascular Systems
• Contego Medical
• InspireMD
• NIPRO
• Silk Road Medical
• Terumo
• Venus Medtech

Looking for more information? Click here

Jessica
Arizton Advisory and Inteligence
+1 312-235-2040
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

I AM CREATING LEARNING THROUGH SONGS. I NEED MENTORS AND PARTNERS.

Daily brain cleaning will enable you into becoming wisdom.

Identitfy with your mind and with it; heal your brain into emotional health.

Know the Level of Your brain You Are Living From.

Know and Harness the Difference Between Your Brain and Mind.

Identify with the mind and with it heal the brain.

use the Brain and Mind to Improve Each Other.

A song is more than a thousand words. Making education a pleasure and a more likely home run.

Creating educational songs to effortlessly embed lessons into the focused as well as the unfocused students. As well as to easily attract and get the uneducated get educated without effort.”

— Sajid Khan

RIDGEFIELD PARK, NJ, UNITED STATES, May 28, 2020 /EINPresswire.com/ — Internet education is now being enhanced with 6 minute videos that visualize the lessons making it easer to digest the subject matter better. As they say a picture is worth a thousand word. Thus with videos learning takes place through the ears as well as the eyes. This internet innovation needs to be brought down into regular classrooms. Just imagine a computer screen as the black board with the teacher instead of writing with a chalk is sitting at a computer writing and explaining the lesson with his fingers. In this corona world order this might just become an innovative necessity.

I would like to add creating learning through songs for several reasons. Songs last longer in memories and thus lessons are easier to remember. Lessons wrapped in music will attract more focus, thus students will pay much more attention. For my particular subject of teaching the science of the art of living not only is there a need to educate the student, there is a need to educate even those who have left the school behind and have missed the education boat.

Just imagine teaching the sciences of life by reducing whole books into a few very short topics through musically appealing songs. Take the topic of upbringing. There is a need to ensure every student to be well prepared for future parenthood and an equally necessary opportunity to teach parents who have missed the wise parenting education. Dragging every uneducated into the classroom will be difficult and logistically impossible. Yet it is imperative that all parents need to be experts in following the path of wise parenting.

Teaching through the ears as well as the eyes, that is soothing to both. Making education a pleasure and a more likely home run.

I have produced two songs that explain the most vital knowledge that needs to be learned by students and the uneducated alike:

Upbringing:
https://songbackup.s3.amazonaws.com/Fixed-Frame-Music-Video-for-upbringing-ayuO-1.zip?AWSAccessKeyId=0PGZHKHH6FCZ5458ZH82&Expires=1591330953&Signature=IQ7gI6L%2BI4xRhiM9rbJeyB8lBik%3D

Wisdom.
https://songbackup.s3.amazonaws.com/Fixed-Frame-Music-Video-for-wisdom-yHQg-1.zip?AWSAccessKeyId=0PGZHKHH6FCZ5458ZH82&Expires=1591331183&Signature=2uAPeTfqqKIFcMmeELsKOmk2yZ8%3D

Our education system is geared towards providing the expertise to earn good money. There is no universal effort to teach how to save and invest money. As a result most people in America earn good money but almost half end up without any savings let alone with any investments.

Again America is an emotionally challenged country because our experts lump the brain and mind as the mind. Thus we have cutting edge mind education while brain education is not only missing, the brain is miseducated.

Our education institutes must note that it is brain education that generates emotional health (EH) that is the foundation of health, education, society, relationships, happiness etc.

Along with short videos I have a plan to create educational songs that will create an emotionally healthy America and the world.

I need partners and mentors.

Sajid Khan
4th R Foundation
+1 201-450-8098
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

My basic hypothesis that has applications in education, health, society, relationships, happiness, peace, deep brain relaxation, upbringing, wisdom, focus etc.


Source: EIN Presswire